Cadila gets USFDA nod to sell generic anti-viral drug

Cadila Healthcare has received approval from the US health regulator USFDA to market anti-viral generic Acyclovir capsules in the American market.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news